Clinical Trials Directory

Trials / Completed

CompletedNCT00577798

Cardiac Magnetic Resonance Imaging in Patients With Non-Hodgkin Lymphoma or Hodgkin Lymphoma Receiving Doxorubicin

Cardiac MRI for Assessment of Cardiac Structure and Function Following Doxorubicin Based Chemotherapy for Newly Diagnosed Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma

Status
Completed
Phase
Study type
Observational
Enrollment
10 (actual)
Sponsor
University of Nebraska · Academic / Other
Sex
All
Age
19 Years – 120 Years
Healthy volunteers
Accepted

Summary

RATIONALE: Diagnostic procedures, such as cardiac magnetic resonance imaging, may help doctors detect early changes in the heart caused by chemotherapy. PURPOSE: This clinical trial is studying how well cardiac magnetic resonance imaging works in patients with newly diagnosed non-Hodgkin lymphoma or Hodgkin lymphoma receiving doxorubicin.

Detailed description

OBJECTIVES: * To determine whether early myocardial structural and functional changes can be detected using cardiac MRI in patients with newly diagnosed non-Hodgkin lymphoma or Hodgkin lymphoma receiving doxorubicin hydrochloride-based chemotherapy. OUTLINE: Patients undergo cardiac MRI with gadolinium contrast prior to initiation of doxorubicin hydrochloride-based chemotherapy and 3 months after completion of six courses of chemotherapy for non-Hodgkin lymphoma and twelve courses of chemotherapy for Hodgkin lymphoma.

Conditions

Interventions

TypeNameDescription
PROCEDUREcontrast-enhanced magnetic resonance imagingCardiac magnetic resonance imaging (cMRI) offers the unique advantage of being able to analyze both function and structure (myocardial changes in the form of both a functional decrease in ejection fraction and structural changes within the myocardium defined as delayed contrast uptake). Participants will have already received doxorubicin hydrochloride as standard therapy when undergoing chemotherapy for non-Hogdkin's lymphoma and Hogdkin's lymphoma.

Timeline

Start date
2008-01-01
Primary completion
2010-03-01
Completion
2013-02-01
First posted
2007-12-20
Last updated
2023-11-03
Results posted
2023-11-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00577798. Inclusion in this directory is not an endorsement.